2025;3:1008128 DOI: Received: July 10, 2025 Accepted: August 18, 2025 Published: September 04, 2025 Academic Editor: Fernando Albericio, University of KwaZulu-Natal, South Africa, Universidad de Barcelona, Spain Metabolic dysfunction-associated steatotic liver disease (MASLD) and its more rapidly progressive variant steatohepatitis (MASH) are widespread chronic liver conditions linked to obesity and other common metabolic disorders
Ozempic and Crohn's Disease: Safety, Risks and Considerations Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for treating type 2 diabetes mellitus
Under the agreement, Natco will manufacture the product, while Eris will lead marketing and distribution across India
An FDA tentative approval means the regulator has completed a scientific assessment, but the product cannot be sold until legal protections expire
Results may vary, but clinical studies have shown that people using Wegovy together with a reduced-calorie diet and increased physical activity experienced significant weight loss within a few months of starting treatment
Consistency is Key : For best results, use regularly for at least 46 weeks